STAMBP and systemic sclerosis: We identify a molecular signature of HICS response in SSc and correlate with potential treatment effect that includes proteins that increase with HICS treatment compared with untreated cases, especially PIIINP, αMSH and ACTH, and also proteins that showed trends of reduction in the HICS-treated subjects.